Upgrade to SI Premium - Free Trial

Arcturus Therapeutics (ARCT) PT Raised to $172 at Brookline Capital Markets, Following Clinical Update

December 7, 2020 11:05 AM
Brookline Capital Markets analyst Kumaraguru ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change

Next Articles